During the past decade, Centre Hospitalier de La Cote Basque; Hematologie conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier de La Cote Basque; Hematologie" #1 sponsor was "French Innovative Leukemia Organisation" with 5 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Celgene" with 1 trials sponsored, "Celgene Corporation" with 1 trials sponsored and "The Lymphoma Academic Research Organisation" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier de La Cote Basque; Hematologie" #1 collaborator was "Acute Leukemia French Association" with 2 trials as a collaborator, "French Intergroup of Myeloproliferative syndromes" with 1 trials as a collaborator, "Group for Research in Adult Acute Lymphoblastic Leukemia" with 1 trials as a collaborator, "Novartis Pharmaceuticals" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier de La Cote Basque; Hematologie" are "Acute Myeloid Leukemia" (4 trials), "Acute Lymphoblastic Leukemia" (1 trials), "Acute Myeloblastic Leukemia" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials) and "Follicular Lymphoma" (1 trials). Many other conditions were trialed in "Centre Hospitalier de La Cote Basque; Hematologie" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier de La Cote Basque; Hematologie" are "Drug" (9 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (3 trials), "CC-5013" (1 trials), "CPX-351" (1 trials), "Chemotherapy (Induction Period)" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier de La Cote Basque; Hematologie" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Centre Hospitalier de La Cote Basque; Hematologie". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Centre Hospitalier de La Cote Basque; Hematologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier de La Cote Basque; Hematologie, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".